Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to ...

U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for priority review with a PDUFA date of July 22, 2025 ...

REDWOOD CITY, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development ...

Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...

Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

From research to 'route of administration' to recovery, when it comes to illicit substances, a little planning goes a long ...

Request To Download Free Sample of This Strategic Report @ Introduction: The hypertension drugs market in Vietnam has witnessed significant growth in recent years, owing to the rising prevalence of ...

Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally represents a ...

In dozens of cities, including Milwaukee, the recent rise of fentanyl has put older Black men in particular jeopardy.

Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium taking ...